Ligand Pharmaceuticals Incorporated (FRA:LGDN)
167.00
+7.00 (4.38%)
Last updated: Jan 7, 2026, 3:55 PM CET
60.58% (1Y)
| Market Cap | 3.50B |
| Revenue (ttm) | 214.13M |
| Net Income (ttm) | 41.41M |
| Shares Out | n/a |
| EPS (ttm) | 2.12 |
| PE Ratio | 84.45 |
| Forward PE | 25.06 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 0 |
| Open | 165.00 |
| Previous Close | 160.00 |
| Day's Range | 165.00 - 167.00 |
| 52-Week Range | 86.00 - 181.00 |
| Beta | n/a |
| RSI | 61.53 |
| Earnings Date | Feb 11, 2026 |